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Abstract Amniotic ﬂuid embolism (AFE) is a rare but potentially catastrophic clinical condition,
characterized by a combination of signs and symptoms that reﬂect respiratory distress,
cardiovascular collapse and disseminated intravascular coagulation (DIC). Its patho-
genesis is still unclear. More recently, the traditional view of obstruction of pulmonary
capillary vessels by amniotic ﬂuid emboli as the main explanation for the etiology has
been ruled out, and immunologic factors and the activation of the inﬂammatory
cascade took on an important role. Amniotic ﬂuid embolism has an unpredictable
character, its diagnosis is exclusively clinical, and the treatment consists mainly of
cardiovascular support and administration of blood products to correct the DIC. No
diagnostic test is recommended until now, though multiple blood markers are
currently being studied. The authors present a case report of a woman who had
survived AFE in her previous pregnancy and had a subsequent pregnancy without
recurrence, providing one more clinical testimony of the low risks for the pregnancy
after AFE.
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Resumo A embolia do liquido amniótico (ELA) é uma situação clínica rara, mas potencialmente
catastróﬁca, que se caracteriza por uma combinação de sinais e sintomas clínicos que
reﬂetem insuﬁciência respiratória aguda, colapso cardiovascular e coagulação intra-
vascular disseminada (CID). A sua patogênese ainda não é totalmente compreendida.
Mais recentemente, a visão tradicional de obstrução dos capilares pulmonares por
êmbolo de líquido amniótico, como explicação principal para a etiologia desta
síndrome, tem sido desconsiderada, assumindo os fatores imunológicos e a ativação
das cascatas de resposta inﬂamatória um papel importante. A embolia do líquido
amniótico tem um carácter imprevisível, e o seu diagnóstico é exclusivamente clínico,
sendo o tratamento sobretudo de suporte respiratório e cardiovascular, com a
concomitante administração de derivados do sangue para corrigir a CID. Nenhum
teste de diagnóstico é recomendado até o momento, embora vários marcadores do
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Introduction
Amniotic ﬂuid embolism (AFE) is a rare obstetric condition,
ﬁrst described in 1926byMeyer1, butonly recognized in 1941,
when Steiner and Lushbaugh2 reported a series of 8 cases of
autopsywith fetalmucinand squamous cells in thepulmonary
vasculature of womenwho had died in a sudden chock during
labor. Its incidence is difﬁcult to determine, with data ranging
from1 in12,953deliveries in theUnited States to 1 in56,500 in
the United Kingdom.3–9 This syndrome has not been clearly
understood to this day, with its pathogenesis being constantly
updated, andwith different roles being played by the amniotic
embolus,2,6 the immune factors10–12 and the inﬂammatory
maternal response to the strange fetal material that enters her
vascular circulation.
It is a catastrophic condition, being responsible for 5–15%
of maternal deaths in developed countries,4 leading the ﬁrst
three causes in those countries. Even though, it seems that
the fatality rate has decreased in the last decades from 86% to
13–44%, and this is probably associated with better recogni-
tion and improvements in the treatment.4,7,8,13 However,
despite the increment in survival, 61% of patients will have
some kind of neurological compromise,5 with neurological
impairment in 50% of the neonates.
This syndrome is characterized byacute respiratory distress
accompanied by cardiovascular collapse and disseminated
intravascular coagulation (DIC) that occurs during pregnancy,
mainly during labor and delivery, until 48 hours postpartum.
Its diagnosis is exclusively clinical, as no marker has yet been
recommended, despite the recent efforts to look for serum
markers in the maternal circulation, such as zinc copropor-
phyrin, sialyl Tn antigen, serum tryptase and C3 and C4
complements.10–12 The histologic value of the presence of
squamous cells in the central venous blood or pulmonary
arterial blood has lost its importance as a pathognomonic, as
several studies showed their presence in non-AFE cases and
only in up to 75% of AFE cases.3,4,14 Moreover, its diagnosis
requires exclusion of other situations that may present with
some of the same signs and symptoms, such as: anesthetic
complications;medication allergy; pulmonary thromboembo-
lism; myocardial infarction; eclampsia; and placental abrup-
tion, among others.4,14–18 More recently, trying to be more
accurate in this diagnosis and for research purposes, interna-
tional criteria for the diagnosis of AFE have been published.19
The treatment relies in early recognition and prompt and
aggressive resuscitative efforts, maintaining vital functions
and transfusing blood products. Some authors even advocate
for the creation of algorithms tomanage DIC in these patients,
as the treatment requires a huge amount of blood products,
considering the transfusion of ﬁbrinogen in the early phases
and of recombinant factor VIIa as a rescue therapy.17,18,20
In the literature, there aremultiple cases and fewseries that
describe the clinical aspects and the support treatments for
this syndrome.9,16,17,20–26 However, information about long-
term maternal and child results is scarce. There are few
published cases of successful pregnancies after AFE survival
in previous gestations,14,27–32 and this case provides another
testimony that pregnancy after AFE can have a good outcome.
Case Report
A 36-year old black woman, born inGuinea-Bissau, in her 6th
gestation (para 3), with a pregnancy followed as low-risk in a
primary care health facility, and no relevant surgical or
medical history, was admitted at her 37th week of gestation
in our hospital in active labor (3 cm of cervical dilatation).
Oxytocin was administered during labor, which devel-
oped quickly, with the dilatation going from 3 cm to 9 cm in 2
hours. At that time, a sudden fetal bradycardia was detected,
and prompt extraction of the soon-to-be neonate was per-
formed with the aid of an extractor-vacuum. The newborn
was male, weighed 3,195 g, had an Apgar Index of 4/7/8, and
was transferred to the neonatal intensive care unit (NICU).
Simultaneously to the extraction of the newborn, the
mother coughed, had a seizure, and, ﬁnally, a cardiac arrest.
Immediate basic cardiorespiratory reanimation was per-
formed, and an anesthesiologist was called. Recovery was
quick, and it was achieved using only venous ﬂuids and
ephedrine, and the third stage of the labor was concluded.
Half an hour later, after an evaluation of the patient by a
neurologist, a post-partum hemorrhage was diagnosed, and it
was treated with 800 μg of rectal misoprostol. Later on, with
the revaluation of the labor canal (which showed no active
wounds), an abdominal ultrasound was performed, and it
showedno evidence of placental debris in uterine cavity. Apart
from that a uterine curettage by ultrasound control was
performed, and it revealed no exit of placental debris. During
this period, the uterus maintained a normal tonus, below the
umbilical scar. Anunsuccessful insufﬂationwith a Sengstaken-
Blackmore balloon was attempted, because of the adequate
uterine tonicity. With these procedures, we were able to rule
out the main causes of post-partum hemorrhage (atonic
uterus, placental debris in the uterine cavity or lacerations of
the labor canal), leaving coagulopathy as the remaining
hypothesis for the cause. At the same time, the laboratory
results showedasuddenalterationwithprolongedcoagulation
times (INR -2.9; aPTT > 160 seconds), absence of ﬁbrinogen
(incoagulable sample), thrombocytopenia (32,000 platelets)
and anemia (7.0 g/dL hemoglobin). The clinical situation
aggravated, with bleeding from venous punctures, hematuria,
and abundant incoagulable vaginal bleeding, with consequent
sangue periférico se encontrem em estudo. Os autores apresentam um caso clínico de
uma mulher que sobreviveu a um quadro de embolia de líquido amniótico na sua
gravidez prévia, e que teve uma gravidez subsequente sem recorrência do quadro,
contribuindo com mais um testemunho clínico do baixo risco na gravidez pós-ELA.
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hypovolemic shock, which was only reverted after intensive
reperfusion with ﬂuids and blood products (10 erythrocyte
concentrate units, 9 fresh frozen plasma units, 14 cryopreci-
pitate units, 2 pools of platelet concentrate and 2 recombinant
ﬁbrinogen units). The womanwas transferred to the intensive
care unit (ICU) with hemodynamic stability and had a full
recovery, beingdischarged fromthehospitalwithher newborn
on the 5th day after birth.
Two years later, the woman got pregnant again, and
because of her labor history, she was examined at our
high-risk pregnancy service, and had a normal pregnancy.
She went into labor at term spontaneously, and had an
eutocic delivery at 39 weeks of gestation. The newborn
weighed 3,100 grams, and had a 9/10 Apgar Index. There
were no postpartum complications, and the patient was
discharged two days later.
Discussion
The described case report demonstrates how dangerous AFE
can be with the imminent risk of death. A multidisciplinary
team was the key for the adequate management, because it
allowed for an immediate response to multiple clinical
issues. In this case, the pregnant woman was multiparous,
and the symptoms presented during labor, with a need to
intervene for suspected fetal distress represented by a
bradycardia, which was recorded in the cardiotocography.
The patient suffered a cardiorespiratory arrest with the
subsequent development of DIC, which progressed to a
serious stage, and a massive transfusion of blood products
was needed. The criteria presented in our case meet the new
criteria that have been proposed by Clark et al regarding AFE
(the symptoms appeared during pregnancy, intensive medi-
cal interventionwas necessary to treat the cardiac arrest and
DIC, there was no other disease that could explain it, and
there was no fever), and also meet their criteria for DIC
during pregnancy (the platelet count was lower than 50,000,
there was an increase of  50% in the coagulation time, and
the ﬁbrinogen levels were untraceable).19
The ﬁrst report of a successful pregnancy after AFE was
published in 1992, with Clark,27 describing 2 cases, and
proposing amore probable model, with AFE involving chem-
ically abnormal amniotic ﬂuid rather than an unusual sensi-
tivity to normal amniotic ﬂuid. Later, in 1998, Duffy28
reported two other cases, and Collier29 reported one, point-
ing out that before 1970 there was a very low probability of
survival for this syndrome, so the hypothesis of another
pregnancy after it was practically impossible. In 2002, Stiller
et al30 described two more cases, followed by another case
described by Demianczuk and Corbett31 in 2005. Finally,
Abecassis and Benhamou32, in 2006, described another case,
and concluded that here was at least a suggestion that there
was little chance of recurrence in a subsequent pregnancy,
and that it was possible for patients who had survived AFE to
become pregnant again and deliver successfully.
These data are still very insufﬁcient, and we believe that
this case provides another testimony of a good outcome, and
it may help on the counselling of these women. However,
clinical information is still scarce in order for us to draw
conclusions, and women’s counselling on the risk of recur-
rence must take into account the severity of this condition
and the few reports known.
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